Capitamall Trust - Stock calls

Date	Analyst	Company	Last	Target	Call	Valuation
04/04/19	Kim Eng	Capitamall Trust	2.41	2.4	Hold	DDM
04/24/19	OCBC	Capitamall Trust	2.32	2.25	Hold
04/25/19	DBS Vickers	Capitamall Trust	2.36	2.55	Buy
04/25/19	OCBC	Capitamall Trust	2.36	2.32	Hold
04/26/19	Phillip	Capitamall Trust	2.39	2.21	Neutral	DDM
04/26/19	CIMB	Capitamall Trust	2.39	2.39	Hold	DDM
05/27/19	UOB Kay Hian	Capitamall Trust	2.44	2.65	Buy	DDM
06/06/19	OCBC	Capitamall Trust	2.46	2.33	Hold
06/19/19	Phillip	Capitamall Trust	2.57	2.21	Neutral
06/21/19	UOB Kay Hian	Capitamall Trust	2.58	2.65	Hold
06/25/19	Kim Eng	Capitamall Trust	2.6	2.4	Hold
07/04/19	DMG & Partners	Capitamall Trust	2.71	2.2	Neutral
07/04/19	DBS Vickers	Capitamall Trust	2.71	2.95	Buy
07/22/19	Phillip	Capitamall Trust	2.64	2.36	Neutral
07/23/19	Lim & Tan	Capitamall Trust	2.6	0	Hold
07/24/19	UOB Kay Hian	Capitamall Trust	2.64	2.65	Hold	DDM, Buy @ $2.42
07/24/19	OCBC	Capitamall Trust	2.64	2.51	Hold
07/24/19	Kim Eng	Capitamall Trust	2.64	2.6	Hold	DDM
07/24/19	DMG & Partners	Capitamall Trust	2.64	2.38	Neutral	DDM
07/24/19	CIMB	Capitamall Trust	2.64	2.6	Hold	DDM
07/25/19	Phillip	Capitamall Trust	2.62	2.68	Neutral	DDM, PB1.09x
08/26/19	Phillip	Capitamall Trust	2.64	2.68	Neutral
09/24/19	Phillip	Capitamall Trust	2.62	2.68	Neutral
10/18/19	Phillip	Capitamall Trust	2.63	2.68	Neutral	DDM
10/22/19	UOB Kay Hian	Capitamall Trust	2.65	2.88	Buy	DDM, PB1.35x
10/22/19	OCBC	Capitamall Trust	2.65	2.73	Hold
10/22/19	DMG & Partners	Capitamall Trust	2.65	2.38	Neutral	DDM
10/22/19	DBS Vickers	Capitamall Trust	2.65	2.85	Buy
10/23/19	CIMB	Capitamall Trust	2.62	2.64	Hold	DDM
11/25/19	Phillip	Capitamall Trust	2.49	2.68	Neutral
12/10/19	DMG & Partners	Capitamall Trust	2.52	2.38	Neutral	DDM
01/23/20	UOB Kay Hian	Capitamall Trust	2.59	2.88	Buy
01/24/20	Phillip	Capitamall Trust	2.57	2.7	Accumulate	DDM
01/24/20	DBS Vickers	Capitamall Trust	2.57	2.95	Buy
03/13/20	Phillip	Capitamall Trust	2.25	2.7	Accumulate
03/17/20	Kim Eng	Capitamall Trust	2	2.7	Buy
03/27/20	UOB Kay Hian	Capitamall Trust	1.78	2.72	Buy	DDM
03/31/20	CIMB	Capitamall Trust	1.75	2.75	Add
04/02/20	DBS Vickers	Capitamall Trust	1.73	1.75	Hold
04/02/20	Kim Eng	Capitamall Trust	1.73	2.7	Buy
04/08/20	OCBC	Capitamall Trust	1.74	2.12	Hold

Capitaland - Stock calls

Date	Analyst	Company	Last	Target	Call	Valuation
04/01/19	UOB Kay Hian	Capitaland	3.65	4.4	Buy
04/02/19	Macquarie	Capitaland	3.69	3.9	Outperform	RNAV (30% discount)
04/02/19	OCBC	Capitaland	3.69	3.98	Buy
05/02/19	Phillip	Capitaland	3.53	4	Accumulate	RNAV (20% discount)
05/02/19	Lim & Tan	Capitaland	3.53	0	Hold
05/03/19	OCBC	Capitaland	3.54	4.04	Buy
05/03/19	CIMB	Capitaland	3.54	3.56	Add
05/27/19	DBS Vickers	Capitaland	3.28	4	Buy	RNAV (25% discount)
06/12/19	DBS Vickers	Capitaland	3.41	4	Buy
06/18/19	Macquarie	Capitaland	3.42	4.1	Outperform	RNAV (25% discount)
07/05/19	DBS Vickers	Capitaland	3.69	4	Buy
07/15/19	Phillip	Capitaland	3.69	4	Accumulate
07/15/19	CIMB	Capitaland	3.69	4.15	Add	RNAV (35% discount)
07/15/19	OCBC	Capitaland	3.69	4.04	Buy
08/07/19	OCBC	Capitaland	3.48	4.04	Buy
08/14/19	Macquarie	Capitaland	3.42	4.15	Outperform
08/19/19	Phillip	Capitaland	3.4	4.2	Buy	PB0.75x FY19
08/20/19	CIMB	Capitaland	3.46	4.15	Add	RNAV (35% discount)
08/22/19	DIR	Capitaland	3.5	4.1	Buy	RNAV (20% discount)
09/05/19	Lim & Tan	Capitaland	3.49	0	Accumulate
09/06/19	DBS Vickers	Capitaland	3.51	4	Buy
10/11/19	Phillip	Capitaland	3.51	4.2	Buy
10/23/19	UOB Kay Hian	Capitaland	3.62	3.8	Hold	Buy @ $3.30
11/06/19	DMG & Partners	Capitaland	3.69	4.2	Buy	RNAV (20% discount)
11/07/19	OCBC	Capitaland	3.66	4.42	Buy	RNAV (15% discount)
11/25/19	CIMB	Capitaland	3.66	4.15	Add
12/02/19	Phillip	Capitaland	3.68	4.2	Buy	RNAV (20% discount)
12/02/19	DMG & Partners	Capitaland	3.68	4.2	Buy	RNAV (20% discount)
12/02/19	UOB Kay Hian	Capitaland	3.68	3.8	Hold	RNAV (20% discount)
12/18/19	Lim & Tan	Capitaland	3.67	0	Hold
01/02/20	DBS Vickers	Capitaland	3.75	4.5	Buy	RNAV (18% discount)
01/08/20	DMG & Partners	Capitaland	3.84	4.2	Buy
01/29/20	Lim & Tan	Capitaland	3.7	0	Hold
02/25/20	Macquarie	Capitaland	3.67	4.15	Outperform
02/26/20	OCBC	Capitaland	3.72	4.42	Buy	RNAV (15% discount)
02/27/20	DMG & Partners	Capitaland	3.67	4.2	Buy	RNAV (20% discount)
02/27/20	OCBC	Capitaland	3.67	4.24	Buy	RNAV (20% discount)
02/27/20	CIMB	Capitaland	3.67	4.25	Add
02/28/20	UOB Kay Hian	Capitaland	3.64	3.7	Hold	Buy @ $3.50
02/28/20	DBS Vickers	Capitaland	3.64	4.5	Buy	RNAV (20% discount)
03/04/20	Phillip	Capitaland	3.58	4.2	Buy	RNAV (20% discount)
03/30/20	DMG & Partners	Capitaland	2.95	4.2	Buy
04/07/20	DMG & Partners	Capitaland	2.74	4.2	Buy

Stock calls for 14 April 2020

Date	Analyst	Company	Last	Target	Call	Valuation
04/14/20	DBS Vickers	CapitaRetail China	1.32	1.55	Buy
04/14/20	OCBC	Frasers Centrepoint Trust	1.93	2.23	Buy
04/14/20	DMG & Partners	Keppel Pacific	0.54	0.76	Buy	DDM
04/14/20	DBS Vickers	Sasseur	0.62	0.8	Buy	DCF, PB0.9x
04/14/20	UOB Kay Hian	Yangzijiang	0.94	1.25	Buy

Taiwan is trying to smear WHO by making a false claim.

https://focustaiwan.tw/politics/202004110004

Taiwan is trying to accuse WHO of dereliction by falsely claiming that it had warned WHO on 31 December 2019 about human-to-human transmission.

Let's look at the email content released below.

"News resources today indicate that at least seven atypical pneumonia cases were reported in Wuhan, CHINA. Their health authorities replied to the media that the cases were believed not SARS; however the samples are still under examination, and cases have been isolated for treatment. I would greatly appreciate it if you have relevant information to share with us. Thank you very much in advance for your attention to this matter."

Taiwan had highlighted in its email content that it had stated that the keyword "isolated" would infer a human-to-human transmission.  However, this is not true because a hospital will isolate a patient for treatment because the patient is highly vulnerable to other infections.  There are many patients with severe illnesses (without contagious diseases) being isolated for treatments because the hospital doesn't want the patients to be infected by other bacteria and/or viruses in the hospital.  Therefore, the keyword "isolated" doesn't mean that the 7 cases are infectious.  The Wuhan hospital was just trying to ringfence the 7 patients so that external factors couldn't interfere with their treatments since there was no scientific evidence to show such human-to-human transmission.  This was, after all, a new unknown virus and nobody had any experience in dealing with it in December 2019.

The Taiwanese email also showed that China didn't cover up its covid-19 outbreak because Taiwan managed to get information from China news media which Taiwan quoted in its email.

In conclusion, Taiwan didn't provide any warning about any human-to-human transmission on 31 Dec 2019 because it was just trying to solicit further information from the WHO.  On the other hand, Taiwan had provided proof that China didn't cover up its covid-19 situation in the email.

We need to give thanks to Taiwan for helping China to clear its name. Hahaha!